The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Regulatory News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.30
Ask: 9.50
Change: -0.35 (-3.59%)
Spread: 0.20 (2.151%)
Open: 9.55
High: 10.00
Low: 9.50
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

4 Sep 2019 11:05

RNS Number : 2099L
e-Therapeutics plc
04 September 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMBGGDCUGGBGCS
Date   Source Headline
15th Mar 20112:47 pmRNSDirector/PDMR Shareholding
15th Mar 201110:35 amRNSHolding(s) in Company
14th Mar 201112:00 pmRNSDirector/PDMR Shareholding
10th Mar 201111:07 amRNSRe-statement of Directors' Interests
10th Mar 201110:20 amRNSHolding(s) in Company
8th Mar 20116:11 pmRNSHolding(s) in Company
8th Mar 20116:01 pmRNSHolding(s) in Company
7th Mar 20118:22 amRNSCompletion of the Placings
4th Mar 20119:13 amRNSDirector/PDMR Shareholding
3rd Mar 20112:08 pmRNSResult of General Meeting
2nd Mar 20119:28 amRNSDirector/PDMR Shareholding
15th Feb 20117:30 amRNSIssue of Equity
3rd Feb 201112:09 pmRNSIssue of Equity
6th Dec 20107:00 amRNSDirectorate Change
29th Oct 20107:00 amRNSe-Therapeutics plc Interim Results
22nd Sep 20107:00 amRNSComprehensive Set of Patents Granted in US
8th Sep 201010:24 amRNSAGM Statement
30th Jul 20108:00 amRNSAnnual Financial Report
29th Jul 201010:23 amRNSAdditional Listing
2nd Jul 20108:00 amRNSDirectors' Interests
29th Jun 20107:00 amRNSFinal Results
25th May 20107:30 amRNSChange of Adviser
29th Apr 20109:02 amRNSIssue of Equity
29th Apr 20107:00 amRNSPre-close operational update and notice of Results
10th Mar 20104:01 pmRNSDirector's interest
2nd Mar 20109:30 amRNSDirector's shareholdings
15th Feb 20107:00 amRNSContract for iGCP trials with Infinitus
11th Nov 20095:46 pmRNSHolding(s) in Company
2nd Nov 200912:00 pmRNSPlacing
30th Oct 20097:00 amRNSInterim results
2nd Sep 200910:05 amRNSResult of AGM
11th Aug 20097:00 amRNSNotice of AGM
27th Jul 20097:42 amRNSPreliminary Results
14th Jul 20097:00 amRNSNotice of Results
25th Jun 20091:00 pmRNSChange of Adviser
17th Jun 20094:05 pmRNSDirector/PDMR Shareholding
9th Jun 200911:36 amRNSDirector Declaration
16th Mar 20094:34 pmRNSResult of General Meeting
11th Mar 20092:19 pmRNSDirector/PDMR Shareholding
25th Feb 20093:00 pmRNSNotice of General Meeting
25th Feb 20097:00 amRNSConditional Investment & Notice of General Meeting
24th Feb 20097:00 amRNSRevenue share agreement with Khandelwal
26th Jan 20097:00 amRNSStrategic Partnership
14th Jan 20097:00 amRNSPositive Phase IIa results for antidepressant
12th Jan 20091:23 pmRNSUS patent granted
12th Nov 20085:04 pmRNSShare Option Award
11th Nov 20083:02 pmRNSGrant of patents
31st Oct 20087:00 amRNSDirector's Shareholding
10th Oct 200812:30 pmRNSPositive PhaseIIa trial of oral asthma drug
8th Oct 20087:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.